UW study suggests Inflation Reduction Act’s $35 out-of-pocket costs for insulin led to a significant increase in prescription fills

A new study by researchers at the University of Wisconsin School of Medicine and Public Health and the University of Southern California Schaeffer Center for Health Policy & Economics found that the $35 cap on monthly out-of-pocket costs of insulin for Medicare beneficiaries has led to a significant increase of insulin prescription fills, especially for Black and Latino patients.